Family Office Insights, BavelasGroup LLC and all affiliates is following the recommendations of the CDC and suggest you do the same. During the outbreak of the virus, in order to protect the health of our friends members and staff.
#Ardour capital series#
He speaks English, French, Spanish, Portuguese and Italian and holds a Series 7, 63 and 24 FINRA licenses. Contact Jean-Marc 91Īlert & disclosure: The Coronavirus (COVID-19) has now been identified in New York City. He became an early stage technology angel investor and then joined Medley Advisors in NYC as a director in 2004. He was named Head of Sales, Americas for Credit Agricole Securities, NY in 1997 until 2001. After graduating from the Jerome Fischer Management &Technology program at the University of Pennsylvania’s Wharton School and Moore School of Engineering in 1983 he worked for Citibank, NY institutional bank and then joined Banque Indosuez trading and sales team in Paris in 1989 becoming the top producing sales person. Since 2005 Jean-Marc has been a director of Ardour Capital Investments, one of the first clean tech focused investment banks and research firms in the U.S. Mount Sinai is a nonprofit institution, and your gift will be fully tax deductible, help to save lives AND help to turn around the economy – a new sort of triple bottom line! This is a profound opportunity for philanthropy. To make a gift, visit here or you can call me directly for more information on 1.917.882.4970. Here is a press release on the entire program ( Mount Sinai Developing an “End-to-End” Diagnostics Solution for COVID-19 That Incorporates Diagnosis, Treatment Selection, and Monitoring of Disease Course) Merad and her team will develop a four-hour test to predict the severity of COVID-19 disease and identify drugs to treat our sickest patients. The outcomes of this research will have an immediate impact in and beyond New York. Merad is working to identify and block the immunological factors that cause death among people with severe COVID-19 in part with drugs already well known and FDA approved. Patients are dying of excess inflammation, and immunotherapy is required to save their lives.
We currently lack treatment for the overwhelming number of severe cases of COVID-19 occurring across the globe every day. I am reaching out in hopes of enlisting your support of a project with enormous promise and real-time impact. Merad and her team are intensely working in response to the COVID-19 (coronavirus) crisis at the US epicenter. Miriam Merad, renowned immunologist and director of Mount Sinai’s Precision Immunology Institute. My son has asthma and given my close connection with Mount Sinai ,where he is treated, I thought a great way to help fight Covid-19 is to find $5MM of funding for the work the Precision Immunology Institute at Mount Sinai in NYC is doing to find a treatment for Covid-19 in anticipation of a vaccine.
#Ardour capital pro#
But when this pandemic hit I had to do my part and so this is completely pro bono on my part. I have been involved with Sustainability and Clean Tech now for about 15 years. Q&A with Jean-Marc O’Brien of Ardour Capital Partner Principal Series:Ī great way to help save lives and reopen the US economy at the same time!
0 kommentar(er)
